The contribution of p53 in the dynamics of cell cycle response to DNA damage interpreted by a mathematical model

Monica Lupi, Giada Matera, Claudia Natoli, Valentina Colombo, Paolo Ubezio

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Despite numerous studies on the tumor suppressor p53, a complete picture of its role in cell arrest and killing in G1, S and G2M phases after drug treatment is lacking. We tackled the analysis of the complexity of cell cycle effects combining the time-course measures with different techniques with the aid of a computer program simulating cell cycle progression. This mixed experimental-simulation approach enabled us to decode the dynamics of the cytostatic and cytotoxic responses to cisplatin and doxorubicin treatments in a p53-proficient colon carcinoma cell line (HCT-116) and in its p53-deficient counterpart. We achieved a separate evaluation of the activity of each cell cycle control and we connected these results with measures of p53 level in G1, S and G2M. We confirmed the action of p53 in all cell cycle phases, but also the presence of strong p53-independent cytostatic and cytotoxic activities exerted by both drugs. In G1 phase, p53 was responsible for a medium/long term block, distinct from the short-term block, which was p53-independent. The delay in traversing S phase was reduced by the presence of p53. In G2M phase, despite a strong p53-independent block, there was a weaker but more persistent p53-dependent block. At cytotoxic concentrations, p53-dependent and p53-independent cell death was observed. The former was poorly phase-specific, occurred earlier and exploited the apoptotic mechanism more than p53-independent death. Computer simulation produced a framework where previous partial and sometimes apparently contradictory observations of the p53-mediated effects could be reconciled and explained.

Original languageEnglish
Pages (from-to)943-950
Number of pages8
JournalCell Cycle
Volume6
Issue number8
Publication statusPublished - Apr 15 2007

Fingerprint

DNA Damage
Cell Cycle
Theoretical Models
Cells
Cytostatic Agents
Mathematical models
S Phase
DNA
G1 Phase
Systems Analysis
Cell Cycle Checkpoints
Pharmaceutical Preparations
Computer Simulation
Doxorubicin
Cisplatin
Colon
Cell Death
Drug therapy
Software
Carcinoma

Keywords

  • Anticancer drugs
  • Cell cycle
  • Cell kinetics
  • Cisplatin
  • Doxorubicin
  • Flow cytometry
  • Mathematical models
  • p53

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

The contribution of p53 in the dynamics of cell cycle response to DNA damage interpreted by a mathematical model. / Lupi, Monica; Matera, Giada; Natoli, Claudia; Colombo, Valentina; Ubezio, Paolo.

In: Cell Cycle, Vol. 6, No. 8, 15.04.2007, p. 943-950.

Research output: Contribution to journalArticle

Lupi, Monica ; Matera, Giada ; Natoli, Claudia ; Colombo, Valentina ; Ubezio, Paolo. / The contribution of p53 in the dynamics of cell cycle response to DNA damage interpreted by a mathematical model. In: Cell Cycle. 2007 ; Vol. 6, No. 8. pp. 943-950.
@article{f282be913dca4d7abf7391bebc4ecd7a,
title = "The contribution of p53 in the dynamics of cell cycle response to DNA damage interpreted by a mathematical model",
abstract = "Despite numerous studies on the tumor suppressor p53, a complete picture of its role in cell arrest and killing in G1, S and G2M phases after drug treatment is lacking. We tackled the analysis of the complexity of cell cycle effects combining the time-course measures with different techniques with the aid of a computer program simulating cell cycle progression. This mixed experimental-simulation approach enabled us to decode the dynamics of the cytostatic and cytotoxic responses to cisplatin and doxorubicin treatments in a p53-proficient colon carcinoma cell line (HCT-116) and in its p53-deficient counterpart. We achieved a separate evaluation of the activity of each cell cycle control and we connected these results with measures of p53 level in G1, S and G2M. We confirmed the action of p53 in all cell cycle phases, but also the presence of strong p53-independent cytostatic and cytotoxic activities exerted by both drugs. In G1 phase, p53 was responsible for a medium/long term block, distinct from the short-term block, which was p53-independent. The delay in traversing S phase was reduced by the presence of p53. In G2M phase, despite a strong p53-independent block, there was a weaker but more persistent p53-dependent block. At cytotoxic concentrations, p53-dependent and p53-independent cell death was observed. The former was poorly phase-specific, occurred earlier and exploited the apoptotic mechanism more than p53-independent death. Computer simulation produced a framework where previous partial and sometimes apparently contradictory observations of the p53-mediated effects could be reconciled and explained.",
keywords = "Anticancer drugs, Cell cycle, Cell kinetics, Cisplatin, Doxorubicin, Flow cytometry, Mathematical models, p53",
author = "Monica Lupi and Giada Matera and Claudia Natoli and Valentina Colombo and Paolo Ubezio",
year = "2007",
month = "4",
day = "15",
language = "English",
volume = "6",
pages = "943--950",
journal = "Cell Cycle",
issn = "1538-4101",
publisher = "Landes Bioscience",
number = "8",

}

TY - JOUR

T1 - The contribution of p53 in the dynamics of cell cycle response to DNA damage interpreted by a mathematical model

AU - Lupi, Monica

AU - Matera, Giada

AU - Natoli, Claudia

AU - Colombo, Valentina

AU - Ubezio, Paolo

PY - 2007/4/15

Y1 - 2007/4/15

N2 - Despite numerous studies on the tumor suppressor p53, a complete picture of its role in cell arrest and killing in G1, S and G2M phases after drug treatment is lacking. We tackled the analysis of the complexity of cell cycle effects combining the time-course measures with different techniques with the aid of a computer program simulating cell cycle progression. This mixed experimental-simulation approach enabled us to decode the dynamics of the cytostatic and cytotoxic responses to cisplatin and doxorubicin treatments in a p53-proficient colon carcinoma cell line (HCT-116) and in its p53-deficient counterpart. We achieved a separate evaluation of the activity of each cell cycle control and we connected these results with measures of p53 level in G1, S and G2M. We confirmed the action of p53 in all cell cycle phases, but also the presence of strong p53-independent cytostatic and cytotoxic activities exerted by both drugs. In G1 phase, p53 was responsible for a medium/long term block, distinct from the short-term block, which was p53-independent. The delay in traversing S phase was reduced by the presence of p53. In G2M phase, despite a strong p53-independent block, there was a weaker but more persistent p53-dependent block. At cytotoxic concentrations, p53-dependent and p53-independent cell death was observed. The former was poorly phase-specific, occurred earlier and exploited the apoptotic mechanism more than p53-independent death. Computer simulation produced a framework where previous partial and sometimes apparently contradictory observations of the p53-mediated effects could be reconciled and explained.

AB - Despite numerous studies on the tumor suppressor p53, a complete picture of its role in cell arrest and killing in G1, S and G2M phases after drug treatment is lacking. We tackled the analysis of the complexity of cell cycle effects combining the time-course measures with different techniques with the aid of a computer program simulating cell cycle progression. This mixed experimental-simulation approach enabled us to decode the dynamics of the cytostatic and cytotoxic responses to cisplatin and doxorubicin treatments in a p53-proficient colon carcinoma cell line (HCT-116) and in its p53-deficient counterpart. We achieved a separate evaluation of the activity of each cell cycle control and we connected these results with measures of p53 level in G1, S and G2M. We confirmed the action of p53 in all cell cycle phases, but also the presence of strong p53-independent cytostatic and cytotoxic activities exerted by both drugs. In G1 phase, p53 was responsible for a medium/long term block, distinct from the short-term block, which was p53-independent. The delay in traversing S phase was reduced by the presence of p53. In G2M phase, despite a strong p53-independent block, there was a weaker but more persistent p53-dependent block. At cytotoxic concentrations, p53-dependent and p53-independent cell death was observed. The former was poorly phase-specific, occurred earlier and exploited the apoptotic mechanism more than p53-independent death. Computer simulation produced a framework where previous partial and sometimes apparently contradictory observations of the p53-mediated effects could be reconciled and explained.

KW - Anticancer drugs

KW - Cell cycle

KW - Cell kinetics

KW - Cisplatin

KW - Doxorubicin

KW - Flow cytometry

KW - Mathematical models

KW - p53

UR - http://www.scopus.com/inward/record.url?scp=34247518636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247518636&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 943

EP - 950

JO - Cell Cycle

JF - Cell Cycle

SN - 1538-4101

IS - 8

ER -